Lower CD44/RHAMM ratios in whole tumor sections were found to be associated with a shorter TFS (cutoff AF = 125.76, p = 0.048), Figure 2I. This was also seen with CD44/RHAMM ratios in intrafollicular areas (cutoff AF = 34.52, p = 0.034), Figure 2J–K. Here, CD44 is linked to neoplasm.